Researchers at MUSC are looking into a novel drug therapy that could help prevent destruction of salvageable neurons after stroke and one day expand the treatments open to patients after stroke.
Related People
The laboratory of Stephen Tomlinson, Ph.D., is focused on the biology of the complement system, and how it modulates an inflammatory response and shapes adaptive immunity. Within the context of complement-modulated immunity, areas of study ...
